Like all holders I’m hoping MDR will break out of its current trading range when the entitlement offer closes. I’m holding a bucket load of shares and didn’t have the available cash to take up my full entitlement. I took up as much as I could afford. I’m excited by the prospect that MDR could be part of the Covid vaccine rollout solution. Adheris is linked to nearly half the American population and has no digital competitor. Remember also that the vaccine may be a multi dose program. The opportunity for MDR to capitalise on this has to be massive. Let’s keep fingers crossed.
Add to My Watchlist
What is My Watchlist?
